1Dunger DB, Ong KK, Sandhu MS. Serum insulin-like growth factor-I levels and potential risk of type 2 diabetes [J]. Horm Res, 2003,60(3):131-135.
2Valverde AM, Burks DJ, Fabregat I, et al. Molecular mechanisms of insulin resistance in IRS-2 deficient hepatocytes[J]. Diabetes, 2003,52(9):2239-2248.
3Araki E,Haag BL 3rd, Matsuda K, et al. Characterization and regulation of the mouse insulin receptor substrate gene promoter[J]. Mol Endocrinol, 1995,9(10):1367-1379.
4Withers DJ, Gutierrez JS, Towery H, et al. Disruption of IRS-2 causes type 2 diabetes in mice[J]. Nature, 1998,391(6670):900-904.
5Bernal D, Almind K, Yenush L, et al. Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians[J]. Diabetes, 1998,47(6):976-979.
6Teno S,Kanno H.Oga S, Increased activity of membrane glycoprotein PC-1 in the fibroblasts from non-insulin dependent diabetes mellitus patients with insulin resistance [J]. Diabetes Res Clin Pract, 1999,45(1):25-30.
7Pizzuti A,Frittitta L,Argiolas A, et al. A polymorphism(K12Q) of the human glycoprotein PC-1gene coding region is strongly associated with inslin resistance[J]. Diabetes, 1999,48(9):1881-1884.
8Eto M, Saito M, Okada M, et al. Apolipoprotein E genetic polymorphism, remanant lipoproteins, and nephropathy in type 2 diabetes patients[J]. Am J Kidney Dis,2002,40(2):243-251.
10Shi Y, Hon M, Ewans RM. The peroxisome proliferator activated receptoro, an integrator of transcriptional repression and nuclear receptor signaling[J]. Proc Nail Acad Sci USA,2002,99(5):2613-2618.
